Drug
Nnc9836 0001
Nnc9836 0001: highest development phase Phase 1, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| NNC9836-0001 NCT07896109 | Phase 1 | Diabetes Mellitus, Type 2 |
Latest
No recent events.
Follow Nnc9836 0001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.